Author Question: An employee's ratings on the dimension of initiative are highly correlated with all of the other ... (Read 105 times)

Caiter2013

  • Hero Member
  • *****
  • Posts: 607
An employee's ratings on the dimension of initiative are highly correlated with all of the other performance appraisal dimensions (e.g., cooperation, job accomplishment, job knowledge). Which type of rating error may be occurring?
 
  a. Central tendency error
  b. Strictness error
 c. Halo error
 d. Proximity error

Question 2

Which type of rating error does not necessarily rate all employees similarly?
 
  a. Strictness error
 b. Leniency error
 c. Central tendency error
  d. Halo



connor417

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

c

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library